Abdelkhalek M, Abdelshafy M, Elhelaly H, Kamal M
Department of Urology, Al-Azhar University, Cairo, Egypt.
Urol Ann. 2013 Jan;5(1):30-3. doi: 10.4103/0974-7796.106963.
Trans-rectal ultrasound (TRUS) is a safe, cost-effective, radiation-free imaging modality for evaluation of prostate. But unfortunately, hemospermia is known to be associated with TRUS-guided prostate biopsy. The aim of this study is to measure the incidence and risk factors of hemospermia in patients undergoing TRUS.
A prospective observational study involving patients undergoing TRUS for suspected prostate cancer has been conducted at Al-Hussein and Sayed Galal Hospitals. Forty patients were included in the study.
Most men (90% = 36 patient) undergoing TRUS-guided prostatic biopsy, who were able to ejaculate, experienced hemospermia, which was associated with some degree of anxiety. The mean duration of hemospermia was 4 (±1.4) weeks. The number of ejaculations before the complete resolution of hemospermia was 6 (±5.6). None of the clinical and pathological factors was a significant predictor of the duration of hemospermia.
Patients should be adequately counseled before TRUS-guided prostatic biopsy to avoid anxiety and alterations in sexual activity.
经直肠超声检查（TRUS）是一种用于评估前列腺的安全、经济高效且无辐射的成像方式。但遗憾的是，已知血精与TRUS引导下的前列腺穿刺活检有关。本研究的目的是测量接受TRUS检查患者血精的发生率及危险因素。
在侯赛因医院和赛义德·加拉勒医院对疑似前列腺癌而接受TRUS检查的患者进行了一项前瞻性观察研究。40名患者纳入本研究。
大多数接受TRUS引导下前列腺穿刺活检且能够射精的男性（90% = 36例患者）出现了血精，这与一定程度的焦虑有关。血精的平均持续时间为4（±1.4）周。血精完全消失前的射精次数为6（±5.6）次。临床和病理因素均不是血精持续时间的显著预测因素。
在进行TRUS引导下前列腺穿刺活检前，应充分对患者进行咨询，以避免焦虑及性活动改变。
